TDG vs VTGN · P/E 41, rev $8.83B vs rev $1.3M
Transdigm Group Incorporated (TDG) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
TDG currently screens at market cap $73.65B and trailing P/E 41.1. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the TDG and VTGN stock pages for the full models.
Not investment advice.